Dongguang, China

Junji Dong

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junji Dong. Retrieved from https://idiyas.com/inventor/junji-dong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junji Dong: Innovator in Humanized Anti-TRKA Antibodies

Introduction

Junji Dong is a prominent inventor based in Dongguang, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work is crucial in advancing therapeutic options for various medical conditions.

Latest Patents

Junji Dong holds a patent for "Humanized Anti-TRKA Antibodies and Uses Thereof." This innovative patent highlights his expertise in creating antibodies that target specific proteins, which can lead to improved treatment strategies for patients.

Career Highlights

Dong is currently employed at Sunshine Lake Pharma Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His dedication to innovation has positioned him as a key figure in the industry.

Collaborations

He has collaborated with notable colleagues, including Zhiheng Ren and Zhuandi He, to further enhance the research and development of new therapeutic solutions.

Conclusion

Junji Dong's contributions to the field of biotechnology, particularly through his patent on humanized antibodies, underscore his role as an influential inventor. His work at Sunshine Lake Pharma Co., Ltd. continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…